Mitochondrial Metabolism

Mitochondrial metabolism compounds act on the respiratory chain, energy coupling and redox balance of mitochondria. In 1961 Mitchell proposed that phosphorylation is coupled to electron transfer through a chemiosmotic mechanism. In this model a proton gradient across the inner membrane drives adenosine triphosphate (ATP) synthase in oxidative phosphorylation (OXPHOS). Rotenone inhibits complex I of the electron transport chain, and oligomycin A blocks ATP synthase. Gboxin, reported in 2019, is an OXPHOS inhibitor that suppresses the growth of glioblastoma cells. Mito-TEMPO is a mitochondria-targeted antioxidant that scavenges superoxide in the matrix. Meldonium inhibits carnitine biosynthesis and so limits fatty acid transport into mitochondria. The set is mixed and also lists compounds with secondary mitochondrial links, such as the fluoroquinolone ciprofloxacin.

6 Items

  • LCL-161
    Cat. No.
    A11928

    LCL-161

    LCL161 is an orally bioavailable second mitochondrial-derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins, with potential antineoplastic activity.

    2 mg
    $55.00
    5 mg
    $75.00
    All 7 sizes
  • ClpP activator-2
    Cat. No.
    A39088

    ClpP activator-2

    ClpP activator-2, or Compound GU18, acts as a specific activator of human ClpP (HsClpP), exhibiting a binding affinity with a Kd of 5.01 μM. This compound enhances the proteolytic function of HsClpP, effectively promoting the degradation of α-casein with an EC50 of 1.09 μM. Additionally, ClpP activator-2 induces mitochondrial reactive oxygen species (ROS) accumulation, resulting in mitochondrial damage and dysfunction. It demonstrates notable anti-multiple myeloma properties in vivo, making it a valuable tool for cancer research and studies targeting mitochondrial dynamics.

    Out of stock

    All 3 sizes
  • HsClpP activator-1
    Cat. No.
    A54490

    HsClpP activator-1

    HsClpP activator-1 is a potent activator of HsClpP, exhibiting an EC50 of 0.22 μM. This compound demonstrates significant biological activity by effectively inhibiting cancer cell growth, with IC50 values ranging from 0.1 to 1 μM. HsClpP activator-1 serves as a valuable tool in cancer research and therapeutic development by modulating protein degradation pathways.

    Out of stock

    All 3 sizes
  • ZW290
    Cat. No.
    A65925

    ZW290

    ZW290 is a selective UCP1 activator that enhances the thermogenic function of brown adipose tissue (BAT). This compound promotes the expression of uncoupling protein 1 (UCP1) and inhibits ATP synthesis, thereby facilitating increased energy expenditure. ZW290 is valuable for research applications focused on metabolism, obesity, and therapeutic strategies targeting energy balance.

    1 mg
    $75.00
    5 mg
    $230.00
    All 4 sizes
  • ZK53
    Cat. No.
    A76692

    ZK53

    ZK53 is a selective activator of human caseinolytic protease P (HsClpP), exhibiting an EC50 of 1.37 µM for alpha-casein hydrolysis. The compound specifically enhances HsClpP activity without affecting bacterial ClpP proteins. In vitro studies demonstrate that ZK53 promotes apoptosis in lung squamous cell carcinoma (LUSC) cell lines, such as H1703, H520, and SK-MES-1, and disrupts mitochondrial functions. Additionally, ZK53 has been shown to inhibit tumor growth in the H1703 xenograft mouse model, making it a valuable tool for cancer research.

    1 mg
    $35.00
    5 mg
    $85.00
    All 6 sizes
  • Speract
    Cat. No.
    A76775

    Speract

    Speract is a peptide derived from sea urchin eggs that acts as a mitochondrial metabolism activator. It enhances sperm motility by stimulating mitochondrial activity, thereby promoting energy production essential for sperm function. This compound is useful in reproductive biology research, enabling studies on sperm physiology and the biochemical pathways regulating motility.

    1 mg
    $55.00
    5 mg
    $200.00
    All 4 sizes

6 Items

Added to your cart

View Cart Checkout

    Loading...